INmune Bio, Inc. (INMB)
1.32
-0.03
(-2.22%)
USD |
NASDAQ |
Feb 19, 16:00
1.31
-0.01
(-0.76%)
Pre-Market: 09:14
INmune Bio Market Cap : 35.09M for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.116B |
| Alnylam Pharmaceuticals, Inc. | 45.01B |
| Savara, Inc. | 1.164B |
| BioMarin Pharmaceutical, Inc. | 12.18B |
| Imunon, Inc. | 6.917M |
Market Cap Related Metrics
| PS Ratio | 624.76 |
| Price to Book Value | 1.383 |
| Price | 1.32 |
| Earnings Yield | -162.1% |